[1]
Bertagnolo, V. et al. 2014. In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness. Italian Journal of Anatomy and Embryology. 118, 2 (Jan. 2014), 25.